Abbott Laboratories Says Its Rapid Coronavirus Test Correctly Identifies Positive Cases 95% of the Time

Abbott Laboratories Says Its Rapid Coronavirus Test Correctly Identifies Positive Cases 95% of the Time

A coronavirus test that attracted some criticism for its accuracy is apparently on the money almost all of the time. On Wednesday, Abbott Laboratories (NYSE: ABT) announced that interim clinical data indicates that its ID NOW COVID-19 test correctly identified positive cases in 95% of instances. ID NOW received emergency use authorization (EUA) from the Food and Drug Administration in March.